Adoption of Euvax-B vaccine in Nineveh
Vaccimonitor (La Habana, Print)
;
30(2)mayo.-ago. 2021. tab, graf
Article
in English
| CUMED, LILACS
| ID: biblio-1252328
ABSTRACT
Hepatitis B infection is one of the most important health problems around the world. The high mortality rate of the hepatitis B encouraged research that led to the finding of an effective vaccine against it. The aim of the present study was to find out the use of the Euvax-B vaccine in sectors of Nineveh province. According to the results obtained in this study, in the next five years, the vaccination coverage for the second and third doses needs to improve(AU)
RESUMEN
La infección por hepatitis B es uno de los más importantes problemas de salud del mundo. La alta tasa de mortalidad de la hepatitis B impulsó las investigaciones que llevaron a encontrar una vacuna eficaz contra la misma. El objetivo del presente estudio fue conocer el uso de la vacuna Euvax-B en sectores de la provincia de Nínive. De acuerdo con los resultados obtenidos, en los próximos cinco años, se debe incrementar la cobertura de inmunización de la segunda y tercera dosis de la vacuna(AU)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Hepatitis B Vaccines
/
Hepadnaviridae Infections
/
Hepatitis B
/
Hepatitis B Surface Antigens
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
English
Journal:
Vaccimonitor (La Habana, Print)
Journal subject:
Molecular Biology
/
Epidemiology
/
Microbiology
/
Vacinas
Year:
2021
Type:
Article
Affiliation country:
Iraq
Institution/Affiliation country:
University of Mosul/IQ
Similar
MEDLINE
...
LILACS
LIS